Skip to content

PHARMACIE E. DOZOT: what changed

What changed

PHARMACIE E. DOZOT

BE 0444.430.838
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€38,700
2024 · €12,908+€25,792
Equity
-€147,015
2024 · -€185,716+€38,700
Cash
€61,923
2024 · €73,505-€11,583
Balance sheet total
€491,246
2024 · €456,157+€35,089

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€25,388

    up €25,388 (+39.2%), from €64,783 to €90,171

    of which Furniture and vehicles: +€42,407

  • Cash -€11,583

    down €11,583 (-15.8%), from €73,505 to €61,923

    mainly Investment in fixed assets (net) (-€53,335) and Trade debts (-€30,137)

  • Stocks and contracts +€10,889

    up €10,889 (+4.8%), from €227,764 to €238,653

  • Receivables within one year +€10,395

    up €10,395 (+11.6%), from €89,460 to €99,855

    of which Trade receivables: +€23,806

Equity and liabilities
  • Reserves +€35,000

    up €35,000 (+48.6%), from €72,000 to €107,000

  • Trade debts -€30,137

    down €30,137 (-12.7%), from €237,473 to €207,336

  • Current portion of long-term debt +€21,083

    up €21,083 (+84.7%), from €24,900 to €45,984

  • Debts after one year +€19,597

    up €19,597 (+36.5%), from €53,702 to €73,299

  • Other debts -€19,143

    down €19,143 (-7.5%), from €256,850 to €237,707

Income statement
  • Gross operating margin +€44,112

    up €44,112 (+17.7%), from €249,658 to €293,770

  • Staff costs +€23,850

    up €23,850 (+13.3%), from €179,777 to €203,627

  • Other operating charges -€7,821

    down €7,821 (-58.5%), from €13,376 to €5,555

  • Financial income +€6,465

    up €6,465 (+2,908%), from €222 to €6,688

  • Depreciation +€5,483

    up €5,483 (+24.4%), from €22,463 to €27,947

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €12,908
Gross operating margin +€44,112
Staff costs -€23,850
Depreciation -€5,483
Other operating charges +€7,821
Financial income +€6,465
Financial charges -€543
Taxes -€2,731
Result 2025 €38,700
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€1,072
Investment -€53,335
Financing +€40,681
Cash 2024 €73,505
Net result for the year +€38,700
Depreciation +€27,947
Stocks and contracts -€10,889
Receivables within one year -€10,395
Trade debts -€30,137
Tax, wage and social debts +€4,989
Other debts -€19,143
Investment in fixed assets (net) -€53,335
Debts after one year +€19,597
Current portion of long-term debt +€21,083
Cash 2025 €61,923
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €456,157 €491,246 +€35,089 +7.7%
Fixed assets 21/28 €65,427 €90,815 +€25,388 +38.8%
Tangible fixed assets 22/27 €64,783 €90,171 +€25,388 +39.2%
Land and buildings 22 €23,763 €18,092 -€5,671 -23.9%
Plant, machinery and equipment 23 €39,157 €27,809 -€11,348 -29.0%
Furniture and vehicles 24 €1,862 €44,269 +€42,407 +2,277%
Financial fixed assets 28 €645 €645 = 0.0%
Current assets 29/58 €390,730 €400,431 +€9,701 +2.5%
Stocks and contracts in progress 3 €227,764 €238,653 +€10,889 +4.8%
Stocks 30/36 €227,764 €238,653 +€10,889 +4.8%
Amounts receivable within one year 40/41 €89,460 €99,855 +€10,395 +11.6%
Trade receivables 40 €68,825 €92,631 +€23,806 +34.6%
Other amounts receivable 41 €20,635 €7,224 -€13,411 -65.0%
Cash at bank and in hand 54/58 €73,505 €61,923 -€11,583 -15.8%
Total equity and liabilities 10/49 €456,157 €491,246 +€35,089 +7.7%
Equity 10/15 -€185,716 -€147,015 +€38,700 +20.8%
Contributions 10/11 €100,000 €100,000 = 0.0%
Reserves 13 €72,000 €107,000 +€35,000 +48.6%
Distributable reserves 133 €72,000 €107,000 +€35,000 +48.6%
Profit (loss) carried forward 14 -€357,716 -€354,015 +€3,700 +1.0%
Amounts payable 17/49 €641,873 €638,262 -€3,611 -0.6%
Amounts payable after more than one year 17 €53,702 €73,299 +€19,597 +36.5%
Financial debts 170/4 €53,702 €73,299 +€19,597 +36.5%
Amounts payable within one year 42/48 €588,170 €564,962 -€23,208 -3.9%
Current portion of amounts payable after more than one year 42 €24,900 €45,984 +€21,083 +84.7%
Financial debts 43 €20,000 €20,000 = 0.0%
Other loans 439 €20,000 €20,000 = 0.0%
Trade debts 44 €237,473 €207,336 -€30,137 -12.7%
Suppliers 440/4 €237,473 €207,336 -€30,137 -12.7%
Taxes, remuneration and social security 45 €48,947 €53,935 +€4,989 +10.2%
Taxes 450/3 €11,630 €12,512 +€882 +7.6%
Remuneration and social security 454/9 €37,317 €41,423 +€4,106 +11.0%
Other amounts payable 47/48 €256,850 €237,707 -€19,143 -7.5%
Remuneration, social security and pensions 62 €179,777 €203,627 +€23,850 +13.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €22,463 €27,947 +€5,483 +24.4%
Other operating charges 640/8 €13,376 €5,555 -€7,821 -58.5%
Gross operating margin 9900 €249,658 €293,770 +€44,112 +17.7%
Operating profit (loss) 9901 €34,041 €56,642 +€22,600 +66.4%
Financial income 75/76B €222 €6,688 +€6,465 +2,908%
Recurring financial income 75 €222 €6,688 +€6,465 +2,908%
Financial charges 65/66B €20,026 €20,568 +€543 +2.7%
Recurring financial charges 65 €20,026 €20,568 +€543 +2.7%
Profit (loss) for the period before taxes 9903 €14,238 €42,761 +€28,523 +200%
Income taxes 67/77 €1,330 €4,060 +€2,731 +205%
Profit (loss) for the period 9904 €12,908 €38,700 +€25,792 +200%
Profit (loss) for the period to be appropriated 9905 €12,908 €38,700 +€25,792 +200%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.